Virtual home hospital care with remote monitoring for acute kidney injury
Official title: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events - Virtual Care: Virtual Home Hospital With Remote Monitoring to Reduce Acute Care Hospitalization
Run by University of Calgary · NCT06537453 · Data updated 2026-11-12
This study is testing whether virtual care and remote monitoring can help adults with acute kidney injury recover better at home and avoid going back to the hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 354 (estimated) |
| Sponsor | University of Calgary Academic / other |
| Locations | 2 sites (Calgary, Alberta and 1 other locations) |
| Status | Recruiting |
| Started | August 10, 2024 |
| Main results expected | June 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT06537453 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are hospitalized adults aged 18 and older diagnosed with acute kidney injury who are at high risk of readmission or death.
✕Probably not a fit
Patients who reside outside Alberta or those with kidney failure requiring dialysis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to implement multi-component digital health solutions to address care gaps for hospitalized adults with acute kidney injury (AKI). By utilizing computerized clinical decision support and virtual care delivered through a hospital-at-home model, the study seeks to reduce hospital stay lengths and readmission rates while improving long-term outcomes. The trial will involve 354 participants and will be conducted over three years at the University of Calgary and University of Alberta. Participants will be monitored remotely to ensure effective management of their condition post-discharge.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery and reduce hospital readmissions for patients with acute kidney injury.
How similar studies have gone: Previous studies have shown success with similar digital health interventions for AKI management, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years old. * AKI identified in hospital using Kidney Disease Improving Global Outcomes (KDIGO) criteria17. * Hospitalization \> 48 hours. * LACE (L= Length patient Stay in the hospital, A= Acuity of Admission of patient in the hospital, C= Comorbidity and E= Emergency Visit.) Score 12 or higher. * Meets all inclusion criteria of Virtual Home Hospital programs of Calgary and Edmonton zones. Exclusion Criteria: * Non-Alberta residents. * Resides outside the catchment areas for the Calgary and Edmonton Virtual Home Hospital programs. * C1 or C2 goals of care. * Hospitalization \> 30 days. * Will be discharged to long-term care. * Kidney failure receiving dialysis. * Already admitted in Virtual Home Hospital Program
Where it's running
-
University of Calgary
Calgary, Alberta, Canada Recruiting -
University of Alberta
Edmonton, Alberta, Canada Recruiting
Study contacts
- Principal investigator: Matthew James, MD — University of Calgary
- Study coordinator: Director
- Email: cccr@ucalgary.ca
- Phone: +1 (403) 210. 6730
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Ischemic Preconditioning at Different Times After Heart Valve Surgery
This study tests whether applying brief, controlled blood-flow restrictions to a limb at different times after heart valve surgery can help protect organs and reduce complications like kidney injury.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Biomarkers to predict CSA-AKI risk before heart surgery
This study tests new biomarkers to see if they can predict CSA-AKI risk in adults undergoing cardiovascular surgery.
-
Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter
This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.
-
Perioperative GFR Monitoring to Predict CSA-AKI and CA-AKI
This study tests whether perioperative transcutaneous fluorescence GFR measurements can predict CSA-AKI or CA-AKI in adults undergoing cardiovascular procedures or iodine contrast exposure.
-
Restarting RAS inhibitors after AKI: a quick test in hospitalized adults
This pilot study tests whether restarting renin-angiotensin system inhibitors early after acute kidney injury is feasible and safe in hospitalized adults already using these medicines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.